- Net sales fell to $27.2 million from $33.99 million in Q3 2025.
- Diluted EPS dropped to -$0.01 compared to +$0.05 in the prior-year period, with net loss of $1.17 million.
- Operating cash flow was $2.6 million, while operating expenses grew despite declining top line.
Why is $NAGE moving today? · SEC 8-K archive
$NAGE SEC Filing Alert & Real-Time AI Stock Impact Analysis
T0 SEO archive for $NAGE: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
FAQ: $NAGE filing catalyst
Why did $NAGE trigger an AI stock catalyst alert?
$NAGE triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: -6.5/10). Headline: Niagen Bioscience Reports Q3 2026 Loss as Revenue Declines 20% YoY. Key points: - Net sales fell to $27.2 million from $33.99 million in Q3 2025. - Diluted EPS dropped to -$0.01 compared to +$0.05 in the prior-year period, with net loss of $1.17 million. - Operating cash flow was $2.6 million, while operating expenses grew despite declining top line.
How did $NAGE stock react after the SEC filing?
After the SEC 8-K for $NAGE, observed market reaction: T0 price $2.52. Past moves do not guarantee future results.
Where can I get real-time $NAGE SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $NAGE via Telegram and the VIP Web Terminal from €10/month.